BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6658459)

  • 1. Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methods.
    Svendsen LG; Fareed J; Walenga JM; Hoppensteadt D
    Semin Thromb Hemost; 1983 Oct; 9(4):250-62. PubMed ID: 6658459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].
    Baskova IP; Paskhina TS; Poliantseva LR; Iakubovskaia RI; Tiero A
    Vopr Med Khim; 1983; 29(5):96-9. PubMed ID: 6557709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasensitive fluorogenic substrates for serine proteases.
    Butenas S; DiLorenzo ME; Mann KG
    Thromb Haemost; 1997 Oct; 78(4):1193-201. PubMed ID: 9364984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
    Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
    Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New chromogenic substrates for thrombin with increased specificity.
    Kolde HJ; Eberle R; Heber H; Heimburger N
    Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptides and fluorogenic substrates related to the reactive site sequence of Kunitz-type inhibitors isolated from Bauhinia: interaction with human plasma kallikrein.
    Oliva ML; Santomauro-Vaz EM; Andrade SA; Juliano MA; Pott VJ; Sampaio MU; Sampaio CA
    Biol Chem; 2001 Jan; 382(1):109-13. PubMed ID: 11258660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system.
    Claeson G
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):411-36. PubMed ID: 8075312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional phenotyping of human plasma using a 361-fluorogenic substrate biosensing microarray.
    Gosalia DN; Denney WS; Salisbury CM; Ellman JA; Diamond SL
    Biotechnol Bioeng; 2006 Aug; 94(6):1099-110. PubMed ID: 16575920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer avenues in the monitoring of antithrombotic therapy: the role of automation.
    Walenga JM; Fareed J; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):346-54. PubMed ID: 6658465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific determination of plasmatic thrombin activity.
    Stief TW
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):324-9. PubMed ID: 16959686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
    Svendsen L; Brogli M; Stocker K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological considerations on chromogenic peptide substrate assays and application on automated analyzers.
    Aasen AO; Kierulf P; Strømme JH
    Acta Chir Scand Suppl; 1982; 509():17-22. PubMed ID: 6187145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood coagulation-fibrinolysis tests by a biochemical method].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1993 Jul; 41(7):743-9. PubMed ID: 8361043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test systems with synthetic peptide substrates in haemostaseology.
    Witt I
    Eur J Clin Chem Clin Biochem; 1991 Jun; 29(6):355-74. PubMed ID: 1912084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemical analysis of blood coagulation factors--with special reference to the test using synthetic peptide substrates].
    Kato H
    Rinsho Byori; 1987 Apr; Spec No 70():43-57. PubMed ID: 3302397
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.